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Background: In Korea, the Korean Laboratory Accreditation Program (KLAP) has set mini-
mum standards for verification of clinical test performance. This verification process is 
time-consuming and labor-intensive when performed manually. We developed a free, sta-
tistical software program for KLAP, using the R language (R Foundation for Statistical Com-
puting, Vienna, Austria). 
Methods: We used CLSI guidelines for the algorithm. We built graphic user interfaces, in-
cluding data input, with Embarcadero Delphi EX4 (Embarcadero Technologies, Inc., Texas, 
USA). The R Base Package and MCR Package for Method Comparison Regression were 
used to implement statistical and graphical procedures.
Results: Our program LaboStats has six modules: parallel test, linearity, method compari-
son, precision, reference interval, and cutoff. Data can be entered into the field either 
manually or by copying and pasting from an MS Excel worksheet. Users can print out pre-
cise reports.
Conclusions: LaboStats can be useful for evaluating clinical test performance characteris-
tics and preparing documents requested by KLAP.
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INTRODUCTION
Medical laboratory services are important for disease diagnosis 
and treatment. Laboratory test results influence 70% of medical 
diagnoses [1]. Errors in test results lead to inappropriate care 
and sometimes death [2, 3]. Medical laboratories should pro-
vide clinicians high quality laboratory services for patient safety. 
The Clinical Laboratory Improvement Amendments (CLIA) of 
1988 require all US clinical laboratories to be regulated for reli-
able and reproducible testing [4]. CLIA regulations address spe-
cific quality requirements that are designed to monitor and im-
prove the quality of the entire testing process. Large medical 
and referral laboratories in the US meet the CLIA requirements 
by following the testing standards of a professional accreditation 
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organization, such as the Joint Commission and the College of 
American Pathologists, recognized by the Centers for Medicare 
and Medicaid Services [5]. The CLIA requirements include 
standards for laboratory personnel, test management, quality 
control, quality assurance, and external quality assessment.
In Korea, 289 medical laboratories met the requirements of 
the Korean Laboratory Accreditation Program (KLAP) and re-
ceived certification in 2016 [6]. During the KLAP inspection, 
various aspects of laboratory operation and management are 
evaluated, including procedure manuals, quality control (QC), 
test management, patient preparation, sample collection, method 
evaluation and test result reporting, laboratory personnel, quality 
assurance, and external quality assessment. 
The KLAP and CLIA have set the minimum standards that 
should be met when verifying clinical test performance. The 
laboratory should verify the performance characteristics: accu-
racy, precision, reportable range, and reference interval [7]. The 
verification process confirms that the instrument and/or test 
method performs as the manufacturer intended when utilized in 
clinical laboratories. In addition, the KLAP and CLIA mandate 
verifying new reagent lot performance. Each new reagent lot has 
the potential to affect QC material and/or patient sample perfor-
mance. Ensuring lot-to-lot consistency is critical for testing, be-
cause small changes in concentration might trigger further test-
ing or other clinical intervention. 
These verification processes are time-consuming and labor-in-
tensive when performed manually using commercial statistical 
software such as Excel (Microsoft, Seattle, WA, USA), SPSS (SPSS 
Inc., Chicago, IL, USA), or MedCalc (MedCalc Software bvba, 
Ostend, Belgium). Therefore, a few commercial programs, such 
as EP Evaluator (Data Innovations, South Burlington, VT, USA) 
and Analyze-It (Analyze-It Ltd, Leeds, UK), have been devel-
oped. These programs are designed to assist the clinical labora-
tory in meeting minimum regulatory requirements for test evalu-
ation and verification. However, they are slightly expensive for 
small laboratories. We therefore designed and evaluated a sim-
ple, automated, free software program, LaboStats, to verify the 
performance characteristics of clinical tests in accordance with 
the CLSI guidelines. LaboStats can be downloaded from the web-
page of the Laboratory Medicine Foundation of Korea (http://
www.lmf.or.kr). 
METHODS
Software design
We examined the KLAP checklists (laboratory organization, ex-
ternal quality assessment, QC, quality assurance, pre-analytic 
process, analytic process, post-analytic process, management of 
laboratory equipment, laboratory personnel, and laboratory envi-
ronment) and computerized them for meeting minimum regula-
tory requirements for test evaluation and verification. The se-
lected checklists included reagent lot comparability test, preci-
sion, method comparison, linearity, reference interval, and cutoff 
for qualitative testing. LaboStats was also intended to generate a 
standardized reporting format showing the results accurately. 
Algorithms
We used the CLSI guidelines as a series of instructions for six 
statistical modules: parallel test, linearity, method comparison, 
precision, reference interval, and cutoff (Fig. 1). The parallel test 
module for reagent lot comparability testing followed the CLSI 
guidelines EP26-A [8]; the linearity module followed the CLSI 
guidelines EP06-A [9]; the method comparison module followed 
the CLSI guidelines EP09-A3 [10]; the precision module followed 
the CLSI guidelines EP15-A3 [11]; the reference interval mod-
ule followed the CLSI guidelines C28-A3c [12]; and the cutoff 
module followed the CLSI guidelines EP12-A2 [13]. 
Software development
Delphi was developed as a rapid application development tool 
for Windows [14]. We built graphic user interfaces, including 
data input, with Embarcadero Delphi EX4 (Embarcadero Tech-
nologies, Inc., Texas, USA). Data was calculated and interpreted 
using the R language (R Foundation for Statistical Computing, 
Fig. 1. Flow chart for computerizing the statistical process for clini-
cal test performance verification.
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Vienna, Austria). R is highly productive for statistical computing 
and modeling; the implementation of statistical and graphical 
procedures is organized in the form of packages. R packages 
are collections of functions and data sets developed by the com-
munity. We used two packages in our software: the R Base Pack-
age and MCR Package for Method Comparison Regression. The 
R Base Package contains the basic functions that enable R to 
function as a language and compute basic statistical properties. 
The MCR Package provides regression methods to quantify the 
relationship between two measurement methods. This package 
enables implementation of Deming regression, weighted Dem-
ing regression, and Passing-Bablok regression following the CLSI 
guidelines EP09-A3 for analytical method comparison and bias 
estimation using patient samples [10].
Comparison of LaboStats with EP Evaluator 
We used the performance evaluation data of new reagents and 
analyzers performed at St. Vincent’s Hospital, Suwon, Korea, in 
2016 to compare the results of LaboStats and EP Evaluator 11.3. 
The evaluation data of 40 test samples were input into the lin-
earity module, method comparison module, precision module, 
and reference interval module of both software programs, and 
the results were compared. We compared the results of the par-
allel test module and cutoff module for LaboStats with the re-
sults obtained manually using the CLSI guidelines EP15-A3 and 
EP12-A2, respectively [11, 13]. Regression parameters for method 
comparison were compared using a paired t-test. P <0.05 was 
considered statistically significant. The statistical analysis was 
performed using SPSS v. 13.0 (SPSS Inc.). For the remaining 
Fig. 2. Data entry user interface of the parallel test module. 
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five modules, we examined whether the results of both programs 
were the same.
RESULTS
Parallel test module
The data entry user interface (UI) of the parallel test module has 
six required data input fields: number of target concentration, 
statistical power, target concentration, critical difference, within-
laboratory imprecision, and within-run imprecision (Fig. 2). The 
number of samples calculation button is enabled once the six 
required fields contain values. Users can choose an appropriate 
level of statistical power: 80%, 85%, 90%, or 95%. The number 
of target concentration ranges between one and three. Clicking 
the calculation button enables the module to calculate the num-
ber of samples to be tested within each target concentration. As 
the ratio of within-run imprecision to within-laboratory impreci-
sion approaches 1.0 and the critical difference increases, the 
number of samples required for the parallel test decreases. Af-
ter determining the number of samples, users can input the 
Fig. 3. Linearity test report. 
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current lot result and candidate lot result in the test result fields. 
Clicking the analysis button will then generate a precise report 
of the parallel test.
Linearity module
The data entry UI of the linearity module has four required data 
input fields: number of target concentration, repeatability, goal 
for nonlinear error, and duplicate results of each diluted sample. 
Once the four required fields contain values, clicking the analy-
sis button will generate a precise report of the linearity test (Fig. 
3). LaboStats, following the CLSI EP06-A [9], performs polyno-
mial regression analysis. Polynomial regression analysis gener-
ates first-order, second-order, and third-order polynomials. The 
best-fitting polynomial can be a first-, second-, or third-order 
polynomial, which shows the smallest difference between the 
measured results and the values obtained from the polynomial. 
Deviation from linearity at each concentration is the difference 
between the value of the best-fitting polynomial and the value of 
Fig. 4. Method comparison report. 
Abbreviation: CI, confidence interval.
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Fig. 5. Data entry user interface of the precision module. 
the first-order polynomial.
Method comparison module
The data entry UI of the method comparison module has four 
required data input fields: number of samples, acceptable bias, 
medical decision points, and test results. The test results can be 
entered into the field either manually or by copying and pasting 
an Excel worksheet. Once the four required fields contain val-
ues, clicking the analysis button will generate a precise report of 
the method comparison (Fig. 4). LaboStats, following the CLSI 
EP09-A3 [10], provides difference plots, scatter plots, ordinary 
linear regression, Deming regression, and Passing-Bablok re-
gression. Estimating bias and its 95% confidence interval (CI) at 
the medical decision points is obtained using Passing-Bablok 
regression analysis. If the 95% CI is within the limits of accept-
able bias, the performance of the candidate measurement pro-
cedure is acceptable. 
Precision module
The data entry UI of the precision module has six required data 
input fields: study period, number of samples, manufacturer’s 
claim for precision (concentration/within-run imprecision/within-
laboratory imprecision), and test results (Fig. 5). The CLSI EP15-
A3 [11] calls for repeated testing of at least two samples for five or 
more days. The basic 5×5 design is five days, one run per day, 
and five replicates per run. One-way ANOVA is the basis for cal-
culating repeatability and within-laboratory imprecision estimates 
for each sample. Once the six required fields contain values, 
Kim Y, et al.
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Fig. 6. Data entry user interface of the cutoff module. 
clicking the analysis button will generate a precise report of the 
precision. The manufacturer’s claim for precision is verified by 
comparing the precision estimate with the manufacturer’s claim. 
Reference interval module
LaboStats provides a tool for validating and establishing the ref-
erence interval. Validating a reference interval requires the mea-
surement of as few as 20 samples from qualified reference indi-
viduals. A minimum sample of 120 reference individuals is rec-
ommended for the establishment of the reference interval. The 
reference interval module performs two general statistical meth-
ods: parametric and nonparametric methods. 
Cutoff module
The data entry UI of the cutoff module has five required data in-
put fields: cutoff concentration, concentration % above cutoff, 
concentration % below cutoff, replicate test number on the same 
sample, and test results (Fig. 6). Once the five required fields 
contain values, clicking the analysis button will generate a pre-
cise report of the cutoff.
Comparison with EP Evaluator
LaboStats showed the same results as EP Evaluator for linearity, 
precision, and validation of reference interval. In the case of 
method comparison, there was no statistically significant differ-
ence in regression parameters between LaboStats and EP Eval-
Kim Y, et al.
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uator. The parallel test and cutoff results using LaboStats were 
the same as the results obtained manually.
DISCUSSION
We developed a free, statistical software program for KLAP, us-
ing the R Language. LaboStats performs a parallel test for which 
EP Evaluator and Analyze-it do not provide a statistic module 
[15]. Reagent lot changes can cause significant shifts in patient 
results [16]. Evaluating lot change is an important part of clini-
cal laboratory practice. However, lot-to-lot verification can vary 
widely across clinical laboratories with regard to the number of 
samples, the type of material, and the criteria used for accep-
tance [17, 18]. The number of samples for lot-to-lot verification 
varies from three to 50 [16, 18, 19]. Increasing the number of 
samples tested will increase the statistical power, but it is costly 
and time-consuming. The CLSI EP26-A is the first guideline 
providing a simple, practical, and statistically sound protocol to 
determine the minimum number of samples tested and inter-
pret the results of the parallel test [8]. However, it is time-con-
suming to perform the parallel test following the instructions of 
the guideline manually [18]; LaboStats makes it easier. 
LaboStats performs a linearity test using polynomial regres-
sion analysis following the CLSI EP06-A guidelines [9]. In gen-
eral, the lack-of-fit (LoF) test has been used to detect nonlinear-
ity [20]. However, the LoF test simply shows whether statistically 
significant nonlinearity exists and does not show where nonlin-
ear range is or magnitude of the nonlinearity [9]. The CLSI EP06-
A, applying polynomial regression, provides a protocol to deter-
mine the concentration at which a method is not linear and the 
extent of the nonlinearity [9]. LaboStats will thus make it easier 
to perform the linearity test.
LaboStats also makes it easier to evaluate method compari-
son, precision, reference interval, and cutoff for qualitative tests. 
In addition, users can print out precise reports with a standard-
ized reporting format. Most laboratories are struggling with doc-
ument control, a common deficiency cited in the College of Amer-
ican Pathologists Laboratory Accreditation Program inspections 
[21]. As KLAP checklists require laboratory personnel to main-
tain many documents on the verification of the performance 
characteristics of clinical tests, standardized reports using our 
software may be helpful in reducing laboratory workload. 
In conclusion, LaboStats can be useful to evaluate the perfor-
mance characteristics of clinical tests and prepare documents 
required by KLAP.
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